Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Anees Mohammad"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Usmani, Asad K.1 asadkusmani@gmail.com, Anees, Mohammad2
Publikováno v:
Adhyayan: A Journal of Management Sciences. 2022, Vol. 12 Issue 2, p47-53. 7p.
Autor:
GHOLVE, SACHIN1 sbgholve@gmail.com, ANEES, MOHAMMAD IMRAN1, SAIFEE, MARIA1, SANGSHETTI, JAIPRAKASH1, BHUSNURE, OMPRAKASH2, BAWAZIR, ABUBAKAR SALAM1
Publikováno v:
International Journal of Pharmaceutical Research (09752366). 2020, Vol. 12 Issue 4, p5041-5053. 13p.
Autor:
Surender M. Kharbanda, Sachchidanand Tiwari, Harshdeep Kaur, Anees Mohammad, Priya Gupta, Harpal Singh
Publikováno v:
Cancer Research. 83:2718-2718
Progression and metastasis of ER+ breast cancer depends on multiple signaling cascades. The available conventional treatment options have limited efficacy in ER+ breast cancer. Simultaneous targeting and inhibition of multiple pathways in ER+ cancer
Publikováno v:
Adhyayan: A Journal of Management Sciences; 2022, Vol. 12 Issue 2, p6-12, 7p
Autor:
Anees Mohammad, Mukesh Kumar
Publikováno v:
International Journal of Research -GRANTHAALAYAH. 5:325-332
This paper try to build up an perceptive of the factors that influence citizens’ adoption of electronic tax-filing services and to discuss taxpayer perception and satisfaction with an online system(e-filing system) for filing individual income tax
Autor:
Sachchidanand Tiwari, Harpal Singh, Neha Mehrotra, Surender Kharbanda, Bozena Korczak, Sireesh Appajosyula, Steve Laumas, Anees Mohammad
Publikováno v:
Cancer Research. 81:3107-3107
Small cell lung cancer (SCLC) is a highly malignant form of lung cancer that accounts for 15% of lung cancer cases. The tumor has a tendency to disseminate early resulting in ~ 85% patients being diagnosed with extensive stage disease (ES-SCLC). Chem
Autor:
Sachchidanand Tiwari, Bozena Korczak, Steve Laumas, Sireesh Appajosyula, Neha Mehrotra, Anees Mohammad, Harpal Singh, Surender Kharbanda
Publikováno v:
Cancer Research. 81:3082-3082
Triple negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and a worse clinical outcome as compared with other breast cancer subtypes. Doxorubicin (DOX) is considered to be one of the most effective agents in the tre
Autor:
Harpal Singh, Surender Kharbanda, Sandeep Laumas, Anees Mohammad, Neha Mehrotra, Sachchidanand Tiwari, Sireesh Appajosyula
Publikováno v:
Journal of Clinical Oncology. 39:e15047-e15047
e15047 Background: Triple negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers and differ from other types of invasive breast cancers in that they grow and spread faster. TNBCs have limited treatment options and a worse progn